MOTIF – Microbicide Optimization Through Innovative Formulation

  • ClientMinnerva Communications

  • DateDec, 2014

  • CategoryCorporate

This study was supported by the European Commission grant MOTIF (Microbicide Optimization Through Innovative Formulation for Vaginal and Rectal Delivery), FP7-HEALTH-2012-305316 Beneficiaries of MOTIF include the University of Aberdeen, the University of Siena, Microbiotec srl, Imperial College, and King’s College London. MICROBIOTEC srl provided support in the form of a salary for MAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.